Canada markets close in 35 minutes

Stereotaxis, Inc. (STXS)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
2.5600+0.2700 (+11.79%)
As of 03:24PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close2.2900
Open2.3200
Bid2.5300 x 900
Ask2.5700 x 2200
Day's Range2.3200 - 2.5950
52 Week Range1.5500 - 5.3800
Volume230,906
Avg. Volume191,581
Market Cap191.602M
Beta (5Y Monthly)1.75
PE Ratio (TTM)N/A
EPS (TTM)-0.2000
Earnings DateNov 10, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.86
  • GlobeNewswire

    Stereotaxis to Report Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023

    ST. LOUIS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2022 fourth quarter and full year ended December 31, 2022 on Friday, March 3, 2023 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments.

  • GlobeNewswire

    Corewell Health Grows Robotic Program to Treat Heart Rhythm Disorders with Adoption of Stereotaxis’ Genesis System

    ST. LOUIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the successful treatment of patients using the latest Genesis Robotic Magnetic Navigation (RMN) system by physicians of the nationally recognized Fred & Lena Meijer Heart Center, part of Corewell Health in Grand Rapids, Michigan. Electrophysiologists at Corewell Health have established a successful robotic cardiac ablation prog

  • GlobeNewswire

    Stereotaxis to Participate in Piper Sandler 34th Annual Healthcare Conference

    ST. LOUIS, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Piper Sandler 34th Annual Healthcare Conference. Mr. Fischel will present on Stereotaxis’ business and technology during a Fireside Discussion on Thursday, December 1, 2022, at 9:00 am ET. He will then join a panel discussion on “The Future of Robotic